Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 6;10(19):6417-6427.
doi: 10.12998/wjcc.v10.i19.6417.

Preliminary evidence in treatment of eosinophilic gastroenteritis in children: A case series

Affiliations

Preliminary evidence in treatment of eosinophilic gastroenteritis in children: A case series

Ying Chen et al. World J Clin Cases. .

Abstract

Background: Eosinophilic gastroenteritis is a rare inflammatory disorder in children. However, there is still no standard guideline in the treatment of pediatric eosinophilic gastroenteritis.

Aim: To report our experience with the diagnosis and treatment of children with eosinophilic gastroenteritis.

Methods: From January 2017 to December 2019, a total of 22 children were diagnosed with eosinophilic gastroenteritis.

Results: Endoscopic examination showed eosinophil infiltration in the duodenum [mean number of eosinophils/high-power field (HPF) = 53.1 ± 81.5], stomach (mean number of eosinophils/HPF = 36.8 ± 50.5), and terminal ileum (mean number of eosinophils/HPF = 49.0 ± 24.0). All 18 children with low eosinophil infiltration (< 14%) responded well to the initial drug treatment without relapse, while two of four children with high eosinophil infiltration (> 14%) relapsed after initial methylprednisolone/montelukast treatment. In addition, children with high eosinophil infiltration (> 14%) showed symptomatic relief and histological remission without further relapse after receiving budesonide/methylprednisolone as initial or relapse treatment.

Conclusion: Methylprednisolone/montelukast is still the best treatment for children with low eosinophil infiltration (< 14%). Budesonide can be considered as the initial or relapse treatment for children with high eosinophil infiltration (> 14%).

Keywords: Absolute eosinophil count; Budesonide; Children; Eosinophil gastroenteritis; Methylprednisolone; Montelukast.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that there is no conflict of interest to disclose.

Figures

Figure 1
Figure 1
Gastrointestinal endoscopy and histopathological examination. A: Gastrointestinal endoscopy depicted erythematous, exudative and erosive gastritis, and congestion in case #21; B: Histopathological examination depicted a high degree of eosinophilic infiltration in case #21 (magnification, 40 ×); C: The gastric mucosa was normal under gastrointestinal endoscopy in case #19; D: Mucosal biopsy revealed a high degree of eosinophilic infiltration in case #19 (magnification, 40 ×).

Similar articles

Cited by

References

    1. Chen B, Yang Z, Lu H, Wei C, Wang F, Liu C. Eosinophilic gastroenteritis presenting as upper gastrointestinal hematoma and ulcers after endoscopic biopsy: A case report and literature review. Medicine (Baltimore) 2017;96:e8075. - PMC - PubMed
    1. Licari A, Votto M, D'Auria E, Castagnoli R, Caimmi SME, Marseglia GL. Eosinophilic Gastrointestinal Diseases in Children: A Practical Review. Curr Pediatr Rev. 2020;16:106–114. - PubMed
    1. Grandinetti T, Biedermann L, Bussmann C, Straumann A, Hruz P. Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab. Dig Dis Sci. 2019;64:2231–2241. - PubMed
    1. Chen PH, Anderson L, Zhang K, Weiss GA. Eosinophilic Gastritis/Gastroenteritis. Curr Gastroenterol Rep. 2021;23:13. - PubMed
    1. Jensen ET, Martin CF, Kappelman MD, Dellon ES. Prevalence of Eosinophilic Gastritis, Gastroenteritis, and Colitis: Estimates From a National Administrative Database. J Pediatr Gastroenterol Nutr. 2016;62:36–42. - PMC - PubMed